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 Abstract 
 Borderline personality disorder (BPD) and substance use dis-
orders (SUDs) often co-occur, partly because they share risk 
factors. In this international multicenter study, risk factors for 
BPD were examined for SUD patients. In total, 1,205 patients 
were comprehensively examined by standardized inter-
views and questionnaires on psychiatric diagnosis and risk 
factors, and it was found that 1,033 (85.7%) had SUDs with-
out BPD (SUD) and 172 (14.3%) had SUD with BPD (SUD + 
BPD). SUD + BPD patients were significantly younger, more 
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often females and more often diagnosed with comorbid 
adult attention deficit/hyperactivity disorder. SUD + BPD pa-
tients did not differ from SUD patients on most risk factors 
typical for SUD such as maternal use of drugs during preg-
nancy or parents having any SUD. However, SUD + BPD pa-
tients did have a higher risk of having experienced emotion-
al and physical abuse, neglect, or family violence in child-
hood compared to SUD patients, suggesting that child abuse 
and family violence are BPD-specific risk factors in patients 
with SUDs.  © 2015 S. Karger AG, Basel 
 Introduction 
 Substance use disorders (SUDs) such as alcohol and/
or drug use disorders are major public health problems 
that have serious biological, psychological, and social 
consequences  [1] . Moreover, individuals with SUDs have 
elevated rates of a host of psychiatric disorders, including 
various personality disorders (PDs)  [2] .
 Psychiatric disorders among patients with SUDs are 
well recognized and of great clinical and public health in-
terest. These so-called ‘dual disorder’ patients have more 
inpatient treatment and a higher prevalence of suicide, 
social problems and medical conditions compared to 
those who have only one psychiatric disorder  [3] .
 There is a strong link between PDs and SUDs, border-
line personality disorder (BPD) in particular  [4] . BPD is 
a common mental disorder with severe functional im-
pairment characterized by interpersonal dysfunction, 
disturbed self-image, emotional instability and impulsiv-
ity. In treatment-seeking psychiatric patients, 10% of out-
patients and 15–25% of inpatients have BPD  [5] .
 Numerous studies have investigated the comorbidity 
of BPD and SUDs. Patients with BPD or antisocial PD 
have the greatest co-occurrence with SUD in both the 
general population and in clinical settings  [4, 6, 7] . In a 
large community sample of nearly 35,000 participants, 
2.7% had BPD. Almost 80% of those were diagnosed with 
a lifetime SUD  [8] . Cross-sectional clinical studies found 
that 23–84% of BPD patients (BPD as the index group) 
met criteria for SUDs  [9] . Conversely, treatment-seeking 
SUD patients (SUD as the index group) have high rates of 
PD, among those 5–22% with BPD  [10] . In a clinical sam-
ple, Morgenstern et al.  [11]  found a BPD prevalence of 
22.4% for patients with alcohol use disorder. Based on the 
findings of these last two studies, up to one fifth of treat-
ment-seeking SUD patients may suffer from a BPD in ad-
dition to a SUD.
 Risk factors are correlates that at least precede and 
change the occurrence of a disorder but are not its con-
comitant or consequence. Risk factors are not necessarily 
causal but a variable or fixed marker of a disorder  [12] . 
For example, risk factors for SUD include alcohol use by 
the mother during pregnancy or a family history of SUD 
 [13–15] .
 Risk factors for BPD are often explained within a bio-
psychosocial model; genetic factors as well as adverse 
childhood events influence biological and psychosocial 
factors which in turn increase the risk of BPD  [5] . Family 
studies have shown an elevated frequency of mood disor-
ders among parents of the BPD patients  [4] . SUD and 
BPD also share certain risk factors. For example, twin 
studies have shown that unique environmental factors in-
crease the risk for both BPD and SUD  [16] . Childhood 
sexual, physical and emotional abuse, violence within the 
family, or neglect are risk factors for BPD  [17–19] as well 
as for SUDs  [1, 13, 15, 20] .
 The aim of this large international multicenter study is 
to examine risk factors such as family history of SUD and 
mood disorders, childhood abuse, and family violence 
comparing SUD patients with BPD (SUD + BPD) with 
patients without BPD comorbidity (SUD). We controlled 
for age, gender and attention deficit/hyperactivity disor-
der (ADHD) to estimate the contribution of each risk fac-
tor. ADHD is generally associated with an elevated risk of 
having a psychiatric disorder, including a BPD diagnosis 
 [21] . In a former data analysis of this large SUD treat-
ment-seeking patient sample, a higher risk for BPD was 
found for SUD patients with ADHD compared to pa-
tients without ADHD  [22] .
 To our knowledge, this is the first study in a large pa-
tient sample investigating the contribution of risk factors 
of BPD in patients with SUD + BPD compared to SUD 
patients.
 Methods 
 Design and Procedure
 The study was conducted by the International Collaboration on 
ADHD and Substance Abuse  [23] and was part of the Internation-
al ADHD in Substance Use Disorder Prevalence (IASP) study. The 
IASP is an international, multicenter, cross-sectional study con-
sisting of a screening stage for ADHD and a diagnostic stage with 
a full assessment of various psychiatric disorders, including BPD 
and SUD. Ten countries (Australia, Belgium, France, Hungary, 
Norway, Spain, Sweden, Switzerland, the Netherlands and the 
USA) with 47 SUD treatment centers participated in the screening 
stage. France, Hungary, Norway, Spain, Sweden, Switzerland and 
the Netherlands also participated in the full assessment, which 
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took place within a few weeks after the screening stage. Treatments 
varied from outpatient to inpatient treatment settings and includ-
ed treatment facilities for alcohol use disorders, drug use disorders 
and mixed SUDs. For a detailed description of the background, the 
study population and the screening results, see van de Glind et al. 
 [24] . The regional ethics committees of all participating countries 
and centers approved the IASP study. Written informed consent 
was obtained from all patients prior to study inclusion. Patients did 
not receive financial compensation, except for those in Australia, 
where patients received AUD 20 compensation for associated 
costs.
 Patients 
 Of the 3,558 SUD treatment-seeking patients, 1,205 agreed to 
participate and completed the full assessment to diagnose psychi-
atric disorders (drop-out rate is discussed in another publication 
 [24] ). Of these 1,205 patients who were comprehensively assessed, 
695 (57.7%) had SUD only and 338 (28.0%) had SUD and psychi-
atric comorbidities other than BPD (e.g. mood disorders, antiso-
cial PD or ADHD). In addition, 172 (14.3%) had comorbid BPD, 
including 50 (4.0%) with BPD comorbidity only. Therefore, the 
present study included two subsamples; 1,205 patients including 
1,033 SUD patients with or without comorbidity other than BPD, 
and 172 SUD  + BPD with or without other current psychiatric 
 disorders.
 Measures 
 For this study, we used the questionnaires and semistructured 
interviews in the full assessment stage of the IASP, all administered 
by trained clinicians. The borderline module of the Structured 
Clinical Interview for DSM-IV personality disorders (SCID II)  [25, 
26] was conducted to assess BPD and the Mini International Neu-
ropsychiatric Interview (M.I.N.I.) Plus version 5.0.0  [27] was used 
to assess prior and current episodes of SUD, mood disorders (e.g. 
major depressive disorder, bipolar disorder) and antisocial per-
sonality disorder according to the DSM-IV criteria. Risk factors 
were evaluated with the Conners’ Adult ADHD Diagnostic Inter-
view for DSM-IV (CAADID) Part I  [28] , a questionnaire that was 
completed by the patient to assess information on developmental 
course and risk factors. The important risk factors for BPD and 
SUD assessed in this study are: mother used alcohol and/or other 
drugs during pregnancy, diagnosis of alcohol and/or other drug 
use disorders of mother and/or father, depression and/or bipolar 
disorders of mother and/or father, childhood abuse (e.g. sexual 
abuse, physical abuse and emotional abuse), physical and emo-
tional neglect, and experience of violence within the family. The 
number of adverse childhood experiences (i.e. sexual abuse, phys-
ical abuse, emotional abuse, physical and emotional neglect and 
violence) was calculated by summing up these five risk factors.
 Statistical Analysis 
 All statistical analyses were conducted using IBM SPSS Statistics 
20.0 for Windows. All statistical tests were two-sided with a 5% sig-
nificance level. To compare demographics and number of risk fac-
tors, independent t-tests and χ 2 -tests were used. The SUD group (in-
dex group) was compared with the SUD + BPD group by using hi-
erarchic logistic regression analyses controlling for age, gender and 
ADHD. We additionally calculated the hierarchic logistic regression 
only with those SUD patients without any other comorbidities than 
BPD to control for other psychiatric comorbidities than BPD.
 Results 
 Among the overall sample of 1,205 patients, 647 were 
single, 212 were married, 225 were divorced, and 107 
lived with a partner (from 14 patients we had no informa-
tion about the social status). Social status did not differ 
between the two groups, but BPD + SUD patients were 
less often employed than SUD patients. SUD + BPD pa-
tients were significantly younger and more likely to be 
female than SUD patients. Hence, we controlled for age 
and gender in all other analyses ( table 1 ). The two groups 
also differed in the rates of comorbidities: compared to 
SUD patients, SUD + BPD patients were more likely to 
meet the criteria for ADHD (29.7 vs. 11.3%, χ 2  = 42.53, 
p  < 0.001), depression (39.0 vs. 16.7%, χ 2   = 45.59, p  < 
0.001) and bipolar disorders (25.9 vs. 3.0%, χ 2  = 90.27, p < 
0.001). In contrast, patients with SUD had used alcohol 
significantly longer (14.4 vs. 10.6 years, t = 4.05, p < 0.001) 
and drank more alcohol per day before entering treat-
ment than patients with SUD + BPD (8.4 vs. 5.4 standard 
drinks (1 standard drink is 10–12 g pure alcohol), t = 3.24, 
p < 0.001). The primary substance of abuse was alcohol 
(n = 665; 55.2%), followed by stimulants (n = 180; 14.9%), 
cannabis (n = 128; 10.6%), opiates (n = 126; 10.5%) and 
other drugs (n = 106; 8.8%). Compared to SUD patients, 
the primary substance of abuse in SUD + BPD patients 
was more likely to be illicit drugs and less likely to be 
 alcohol.
 Except for ‘mother used alcohol during pregnancy’, 
the two groups did not differ in SUD-specific risk factors. 
However, compared to SUD patients, SUD + BPD pa-
 Table 1. Patients’ characteristics
Total
(n = 1,205)
SUD
(n = 1,033)
SUD + BPD
(n = 172)
χ2/t
Male 73.4 76.9 52.9 41.42**
Age, years 40.0±11.2 40.7±11.2 35.6±9.9 6.13**
Social status
Single
Married
Divorced
Living with 
partner
54.3
17.8
18.9
9.0
53.4
18.8
18.8
9.1
60.1
11.9
19.6
8.3
5.18
Employed 30.9 32.3 22.1 6.43*
Main substance
Alcohol
Drugs 
55.2
44.8
57.6
42.4
40.7
59.3
17.84**
 Values represent % or means ± SD. * p < 0.05; ** p < 0.001.
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tients were significantly more likely to report the com-
mon risk factors of having experienced physical abuse, 
emotional abuse, neglect or family violence in childhood 
( table 2 ). Less than 1% of the mothers of the SUD patients 
(0.8%) and SUD + BPD patients (0.6%) consumed drugs 
during pregnancy; therefore, statistical analysis is not ap-
propriate. While there was no overall difference between 
SUD and SUD + BPD patients with regard to the preva-
lence of childhood sexual abuse, there was a significant 
gender difference with more women reporting sexual 
abuse than men (28.1 vs. 8.0%, χ 2  =  77.9, p < 0.001).
 In order to control for possible group differences re-
garding the presence of comorbid psychiatric disorders 
other than BPD, a comparison of risk factors between the 
695 SUD-only and the 50 SUD + BPD-only patients was 
performed, again controlling for sex, age and ADHD. 
The results were similar to those from the comparison of 
the broader SUD and SUD + BPD groups: parental his-
tory of depression (OR = 1.03, p = 0.94, CI: 0.50–2.14), 
parental history of bipolar disorder (OR = 0.83, p = 0.81, 
CI: 0.18–3.80), number of adverse events (OR = 0.78, p = 
0.01, CI: 0.67–0.94), childhood sexual abuse (OR = 1.12, 
p = 0.78, CI: 0.50–2.49), physical abuse (OR = 2.09, p = 
0.03, CI: 1.09–3.99), emotional abuse (OR  = 2.71, p  = 
0.002, CI: 1.44–5.09), neglect (OR = 2.27, p = 0.02, CI: 
1.12–4.61) and violence within the family (OR = 1.58, p = 
0.18, CI: 0.81–3.06). Moreover, the SUD-specific risk fac-
tors did not differ significantly between the two groups: 
maternal use of alcohol during pregnancy (OR = 1.96, 
p  = 0.15, CI: 0.79–4.87), parental alcohol use disorder 
(OR = 1.03, p = 0.92, CI: 0.53–2.02) and parental drug use 
disorder (OR = 1.14, p = 0.82, CI: 0.39–3.33). None of the 
mothers of the SUD + BPD patients consumed drugs 
during pregnancy; therefore, a statistical calculation is 
not possible.
 Discussion 
 This is the first international multicenter study evalu-
ating SUD and BPD risk factors among a large sample of 
treatment-seeking SUD patients with and without co-
morbid BPD using the same standardized interviews by 
trained clinicians. In the primary analysis, we included 
patients with other current comorbidities. The potential 
influence of co-occurring disorders (e.g. mood disorders, 
antisocial PD) was explicitly excluded in the secondary 
analysis by restricting the sample to patients with SUD 
only and BPD + SUD only. The results of both analyses 
were very similar, suggesting that they are generalizable 
to most clinical samples of treatment-seeking SUD pa-
tients with or without BPD.
 Table 2. Logistic regressions with risk factors as the independent variable and SUD/SUD + BPD as the dependent variable controlled 
for age, gender and ADHD
SUD
(n = 1,033)
SUD + BPD
(n = 172)
b (SE) Wald OR (95% CI)
Patients’ characteristics
Male 76.9 52.9 –1.18 (0.18) 44.34** 0.31 (0.22–0.43)
Age 40.7±11.2 35.6±9.9 –0.04 (0.01) 21.32** 0.96 (0.95–0.98)
ADHD 11.3 29.7 1.15 (0.21) 31.44** 3.16 (2.12–4.73)
Risk factors
Mother drank alcohol during pregnancy 9.8 18.9 0.79 (0.25) 10.35* 2.20 (1.36–3.56)
Parental alcohol use disorder 26.3 28.5 –0.18 (0.35) 0.84 0.84 (0.57–1.23)
Parental drug use disorder 5.8 8.7 0.01 (0.33) 0.01 1.00 (0.53–1.91)
Parental history of depression 17.6 26.7 0.15 (0.21) 0.52 1.16 (0.78–1.74)
Parental history of bipolar disorder 4.7 7.6 0.07 (0.35) 0.04 1.07 (0.54–2.13)
Childhood sexual abuse 13.1 19.9 –0.06 (0.24) 0.05 0.95 (0.56–1.52)
Childhood physical abuse 25.2 46.6 0.82 (0.18) 19.70** 2.27 (1.58–3.25)
Childhood emotional abuse 34.5 58.4 0.71 (0.18) 14.84* 2.03 (1.42–2.91)
Childhood physical/emotional neglect 18.6 44.1 1.03 (0.19) 29.41** 2.80 (1.93–4.07)
Violence within family 25.6 39.1 0.41 (0.19) 4.88* 1.51 (1.05–2.18)
Number of adverse events 4.6±1.7 3.6±1.8 –0.22 (0.05) 19.40** 0.80 (0.72–0.88)
Values represent % or means ± SD. * p < 0.05; ** p < 0.001.
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 The first main finding was that patients with SUD + 
BPD had higher frequencies of physical and emotional 
neglect and abuse in childhood and were more likely to 
have a childhood history of family violence, irrespective 
of the presence of other psychiatric comorbidity, sug-
gesting that increased childhood adversity is an inde-
pendent risk factor for BPD in treatment-seeking SUD 
patients. For example, the risk of having experienced 
physical and emotional neglect was 2.8 times higher 
among SUD + BPD patients (45%) than for SUD pa-
tients (19%). As expected, the two groups did not differ 
in family history of SUD except that the mothers of the 
SUD + BPD patients were more likely to drink alcohol 
during pregnancy than the mothers of the SUD patients, 
suggesting an impact of alcohol on the unborn child 
might be associated with BPD. Alternatively, mothers of 
the SUD + BPD patients were more likely to drink alco-
hol during pregnancy because they were more impul-
sive and had problems to abstain from alcohol or at least 
to control drinking. However, this significance disap-
peared when the SUD-only group was compared with 
the BPD + SUD-only group. Thus, the impact of mater-
nal alcohol use during pregnancy seemed to be more 
likely associated with the presence of other psychiatric 
comorbidities.
 Our findings showed that the number of adverse 
childhood experiences was higher in SUD patients than 
in SUD + BPD patients. Nevertheless, the number of 
adverse childhood experiences does not seem to be a 
measure of the severity and repetition of traumatic 
events since severe childhood traumatic experiences 
were more frequent in SUD + BPD patients compared 
to SUD patients. It is rather a measure of the quantity 
of the different experiences. Unexpectedly, many SUD 
patients, either with or without BPD, reported not hav-
ing been exposed to these risk factors. Other risk factors 
not assessed in this study such as underlying genetic 
vulnerability may also contribute to SUD and comorbid 
disorders.
 The second main finding was that there were demo-
graphic differences between SUD and SUD + BPD pa-
tients. The two groups differed in gender; there were sig-
nificantly more women with SUD + BPD comorbidity 
than men. This is consistent with findings from other 
non-SUD treatment settings showing higher rates of BPD 
among female patients than among male patients  [29, 30] . 
However, epidemiological studies of BPD based on data 
from a community sample have not found significant dif-
ferences in gender, suggesting that gender differences in 
BPD are only true for patients ascertained in treatment 
settings, but not for those ascertained in the community 
 [8, 31, 32] . In addition, SUD + BPD patients were young-
er than patients with SUD only. This result is consistent 
with studies reporting that BPD begins in adolescence, 
peaks in young adulthood and that most patients recover 
from BPD with time  [8, 33] . Moreover, patients with BPD 
may develop SUD at a younger age and develop a more 
severe SUD; therefore, it is possible that they seek treat-
ment at a younger age. Further, when controlling for co-
morbidity with ADHD  [22] and other comorbidities, the 
risk factors for BPD in SUD patients remain significant, 
suggesting that childhood abuse (except sexual abuse) 
and family violence are important risk factors for BPD in 
SUD patients.
 When interpreting the findings, the following limita-
tions should be taken into account. First, some of the risk 
factors assessed may be confounded. Physical abuse, for 
example, is associated with emotional abuse. Thus, it is 
difficult to disentangle these risk factors. Moreover, some 
BPD risk factors are missing in the IASP study (e.g. fam-
ily history of impulsivity). Second, sensitive information 
such as adverse childhood experiences may be underre-
ported. However, we have no reason to expect that under-
reporting would differ between the two groups. Third, we 
did not consider SUD as a risk factor for BPD or vice 
versa. For example, early substance use and heavy drink-
ing in adolescence may promote the development of BPD 
by the negative impact of alcohol on the emotional regu-
lation system. In contrast, twin analyses revealed that, at 
least in 14- to 18-years old adolescents, comorbidity be-
tween BPD traits and substance use is rather a conse-
quence of common vulnerability and shared risk factors 
than due to one disease serving as a cause of the other 
 [34] . Further prospective and longitudinal studies are 
needed to clarify the causal links between BPD and SUD. 
Fourth, while most of the data including the diagnoses 
were assessed using validated structured and standard-
ized clinical interviews (e.g. SCID II, M.I.N.I. Plus 5.0.0, 
CAADID Interview for ADHD), risk factors were self-
reported in the questionnaire part of the CAADID and 
are potentially subject to recall bias. In order to minimize 
recall bias in future research, longitudinal studies and 
 external assessments are recommended. Moreover, it is 
important to use a more specific instrument such as the 
Childhood Trauma Questionnaire (CTQ)  [35] and to in-
clude genetic vulnerability in further studies  [34] . Fifth, 
in our study significantly more patients with SUD + BPD 
than with SUD also have ADHD. Because there is some 
overlap between the diagnostic criteria of BPD and 
ADHD (e.g. impulsivity), it is possible that patients were 
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misdiagnosed with BPD and only had ADHD or vice ver-
sa. Finally, we did not have a BPD-only comparison group 
in the current study. As such, we were not able to evaluate 
the unique contribution of BPD specific risk factors.
 Conclusions 
 As expected, there were no differences in the majority 
of risk factors for SUD between SUD patients with and 
without comorbid BPD. However, known risk factors for 
BPD such as childhood abuse and family violence were 
considerably more frequent in SUD patients with BPD, 
suggesting that childhood abuse and family violence were 
risk factors for BPD comorbidity among those suffering 
from SUDs. Thus, clinicians treating patients with both 
SUD and BPD should be aware of the elevated risk of ex-
perienced violence as a child and the need for targeted 
treatment strategies that consider this victimization.
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